NKTX stock touches 52-week low at $1.44 amid market challenges
NKTX Stock Touches 52-Week Low at $1.44 Amid Market Challenges March 25, 2025 – New York, NY NKTX, the biopharmaceutical company known for its cutting-edge research in immunotherapy, has seen its stock price plunge to a 52-week low of $1.44, sparking concern among investors and analysts alike. The stock’s dramatic decline comes amid an array … Read more












